MolNFT v1 · #6418 · protein
Structure-based design of a novel, osteoclast-selective, nonpeptide src SH2 inhibitor with in vivo anti-resorptive activity
1FBZ: “Structure-based design of a novel, osteoclast-selective, nonpeptide src SH2 inhibitor with in vivo…”. X-ray diffraction. MolNFT v1 #6418 on GenesisL1: 3D structure, binding sites and pockets in GL1X.
- PDB
- 1FBZ
- Type
- protein
- Length
- 208 residues
- Chains
- 2
- Method
- x-ray diffraction
- Collection
- MolNFT v1 / PDB
- Contract
- 0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
- Owner
- 0x3396CDB397284571d12822B4ae1189a8E22AAAAA
- UniProt
- P06239
Structure
x-ray diffraction · 1 distinct chain.
| Chain | Molecule | Type | Residues | Secondary structure | UniProt |
|---|---|---|---|---|---|
| A, B | — | protein | 104 | — | P06239 |
Compared structures
- 1FBZ · Structure-based design of a novel, osteoclast-selective, nonpeptide Src SH2 inhibitor… · the same entry in another collection · chain A against A, TM-score 1.00
- P06239 · AlphaFold monomer V2.0 prediction for tyrosine-protein kinase lck (P06239) · a predicted model of the same protein · chain A against A, TM-score 0.95
Analyse
- Open in the research workbench: secondary structure, accessibility, pockets, interfaces, conservation, variants, modifications, peptides and crosslinks on the 3D structure
- Every structure of UniProt P06239
- Elsewhere: RCSB PDB 1FBZ · PDBe 1FBZ · UniProt P06239
GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.